KeyBanc analyst Paul Knight raised the price target on Repligen (NASDAQ: RGEN) to $335.00 (from $255.00) while maintaining an Overweight ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE